Ausgabe 3/2018
Inhalt (24 Artikel)
Iron overload impact on P-ATPases
Leilismara Sousa, Marco Tulio C. Pessoa, Tamara G. F. Costa, Vanessa F. Cortes, Herica L. Santos, Leandro Augusto Barbosa
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Xavier Leleu, Francesca Gay, Anne Flament, Kim Allcott, Michel Delforge
A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review
Fabrice Coutier, Nadine Meaux Ruault, Thomas Crepin, Kevin Bouiller, Helder Gil, Sébastien Humbert, Isabelle Bedgedjian, Nadine Magy-Bertrand
Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia
Hongli Zhao, Yanqiu Zhao, Yingmei Zhang, Jinxiao Hou, Huiyuan Yang, Fenglin Cao, Yiju Yang, Wenyi Hou, Jiayue Sun, Bo Jin, Jinyue Fu, Haitao Li, Ping Wang, Fei Ge, Jin Zhou
Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases
Haigang Shao, Jiannong Cen, Suning Chen, Huiying Qiu, Jinlan Pan
Bone marrow findings in blast phase of polycythemia vera
Juliana E. Hidalgo López, Adrian Carballo-Zarate, Srdan Verstovsek, Sa A. Wang, Shimin Hu, Shaoying Li, Jie Xu, Wenli Zuo, Zhenya Tang, C. Cameron Yin, L. Jeffrey Medeiros, Carlos E. Bueso-Ramos, Guilin Tang
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation
Andrew T. Kuykendall, Savan Shah, Chetasi Talati, Najla Al Ali, Kendra Sweet, Eric Padron, David A. Sallman, Jeffrey E. Lancet, Alan F. List, Kenneth S. Zuckerman, Rami S. Komrokji
Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up
Alicia Senín, Concepción Fernández-Rodríguez, Beatriz Bellosillo, Laura Camacho, Raquel Longarón, Anna Angona, Carles Besses, Alberto Álvarez-Larrán
High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China
Chaoyu Wang, Bing Xia, Qiaoyang Ning, Haifeng Zhao, Hongliang Yang, Zhigang Zhao, Xiaofang Wang, Yafei Wang, Yong Yu, Yizhuo Zhang
Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study
Marina Davidov, Chava Perry, Yair Herishanu, Nadav Sarid, Esti Rom, Odelia Amit, Rinat Eshel, Ella Naparstek, Irit Avivi, Ron Ram
Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma
M. Lokvenc, Marketa Kalinova, K. Forsterova, P. Klener, M. Trneny, E. Fronkova, R. Kodet
Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study
Cristina Jiménez, María Isabel Prieto-Conde, María García-Álvarez, Miguel Alcoceba, Fernando Escalante, María del Carmen Chillón, Alfonso García de Coca, Ana Balanzategui, Alberto Cantalapiedra, Carlos Aguilar, Rocío Corral, Tomás González-López, Luis A. Marín, Abelardo Bárez, Noemí Puig, Aránzazu García-Mateo, Norma C. Gutiérrez, María Eugenia Sarasquete, Marcos González, Ramón García-Sanz
CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens
Xiao-Ying Qin, Jin Lu, Guo-Xuan Li, Lei Wen, Yang Liu, Lan-Ping Xu, Ying-Jun Chang, Kai-Yan Liu, Zheng-Fan Jiang, Xiao-Jun Huang
Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia
Jun Yang, Yu Cai, JieLing Jiang, LiPing Wan, HaiTao Bai, Jun Zhu, Su li, Chun Wang, Xianmin Song
Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation
Alicja Sadowska-Klasa, Agnieszka Piekarska, Witold Prejzner, Maria Bieniaszewska, Andrzej Hellmann
Correlation of sociodemographic and clinical parameters with depression and distress in patients with hematologic malignancies
Amanda J. Shreders, Shehzad K. Niazi, David O. Hodge, Nicolette T. Chimato, Megha Kureti, Navya Kirla, Ankit Agrawal, Abhisek Swaika, Elaine Gustetic, Renee Foster, Kimberly A. Nelson, Prachi Jani, Asher A. Chanan-Khan, Sikander Ailawadhi
Simultaneous occurrence of two distinct leukemic clones with PML-RARα and RUNX1-RUNX1T1 in a case of acute myeloid leukemia
Haigang Shao, Qian Yang, Ping Zhang, Hengfang Liu, Chunxiao Wu, Jiannong Cen, Huiying Qiu, Suning Chen, Jinlan Pan
KIT D816V− chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation
Concepción Prats-Martín, Patricia Jiménez-Guerrero, Rosario M. Morales-Camacho, Teresa Caballero-Velázquez, M. Teresa Vargas, Olga Pérez, Isabel Montero, José Falantes, Sergio Burillo-Sanz, Estrella Carrillo, Juan J. Borrero, Ricardo Bernal, J. A. Pérez-Simón
Epstein-Barr virus clonality and plasmacytosis in a patient with atypical angioimmunoblastic T cell lymphoma
Shuhei Okuyama, Taichi Terada, Hiroaki Kumagai, Riko Tsumanuma, Eijiro Omoto, Tetsuya Ueki, Naoki Yanagawa, Kunihiko Maeda, Katsushi Tajima
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine
Marc Hilmi, Cécile Bally, Robert Burns, Gwenael Lorillon, Anne Bergeron, Pierre Fenaux, Lionel Ades
Paraneoplastic pemphigus without detectable anti-plakin antibodies in a patient with non-Hodgkin lymphoma
E. Moreno-Artero, E. Querol-Cisneros, N. Rodríguez-Garijo, A. Tomás-Velázquez, M. A. Idoate, N. Ishii, T. Hashimoto, Agustín España
A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder: is there a link between metastasis and factor deficiency in solid tumors?
T. Cammaert, K. Decaestecker, N. Sundahl, S. Rottey, K. M. J. Devreese
Sclerosing mesenteritis as a presentation of myelodysplastic syndrome (MDS) with improvement following treatment targeted at MDS
Radowan Elnair, Prince Sethi, Tarek Hassouna, Ahmed Galal
Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin
Jamilla Li, Joycelyn Sim, Anskar Y. H. Leung, Yok-Lam Kwong